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ABSTRACT 
 
Pregnancy and childbirth are both natural occurring events, but still little is known about 
the signaling mechanisms that induce contractions.  Throughout the world, premature 
labor occurs in 12% of all pregnancies with 36% of infant deaths resulting from preterm 
related causes.  Even though the cause of preterm labor can vary, understanding 
alternative signaling pathways, which affect muscle contraction, could provide additional 
treatment options in stopping premature labor.  The uterus is composed of smooth 
muscle, which is innervated, with a plexus of nerves that cover the muscle fibers.  
Smooth muscle can be stimulated or modulated by many sources such as 
neurotransmitters [i.e. dopamine], hormones [i.e. estrogen], peptides [i.e. oxytocin] and 
amines. This study focuses on the biogenic monoamine tyramine, which is produced in 
the tyrosine catecholamine biosynthesis pathway.  Tyramine is known to be associated 
with peripheral vasoconstriction, increased cardiac output, increased respiration, elevated 
blood glucose and the release of norepinephrine. This research has found tyramine, and 
its specific receptor TAAR1, to be localized within mouse uterus and that this 
monoamine can induce uterine contractions at levels similar to oxytocin. 
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Chapter 1.  Pregnancy and the Modulators of Uterine Smooth Muscle 
Introduction 
Childbirth is a natural part of life and has been studied throughout time to provide 
adequate pre- and post-care in order to reduce injury or fatality to both moms and babies. 
One of the leading causes of death among newborns is due to pre-term labor. According 
to the World Health Organization, preterm labor is defined as babies who are born alive 
before thirty-seven weeks of pregnancy are completed.  There are three sub-categories of 
preterm birth, based on gestational age.  Those categories are: extremely preterm (less 
than twenty-eight weeks), very preterm (ranging from twenty-eight to thirty-two weeks), 
and moderate to later preterm (ranging from thirty-two to thirty-seven weeks).  In some 
cases a birth must be induced early to protect the health of the mother or the fetus but 
more often it is the result of rupture of membranes, hemorrhage, hypertension or 
weakened cervix.  Multiple as well as single births associated with assisted reproductive 
technologies are also a contributing factor to the overall increase in preterm births 
(Jackson et al., 2004). As technology improves, researchers continue to investigate the 
mechanisms, which control gestation and birth in hopes of reducing the frequency of pre-
term labor. 
Causes of pre-term labor 
There are many risk factors that are believed to interact that cause the transition 
from the relaxed state of the uterus toward pre-term labor. Currently there are three 
accepted theories that explain the onset of labor.  The first theory is progesterone 
withdrawal, which stems from a sheep study. According to Ligging et al., (1977), as 
parturition nears, the fetal-adrenal axis becomes more sensitive to adrenocorticotropic 
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hormone, increasing the secretion of cortisol. Fetal cortisol stimulates placental 17α-
hydroxylase activity, which decreases progesterone secretion and increases estrogen 
production. The reversal in the estrogen/progesterone ratio results in increased 
prostaglandin formation, initiating a cascade of events that culminates in labor. In 
humans, the concentrations of serum progesterone do not decrease as labor approaches; 
and because progesterone antagonists such as RU486 initiates pre-term labor and 
progestational agents prevent pre-term labor, a decrease in the concentrations of 
progesterone or a decrease in the number of receptors is a reasonable mechanism for the 
initiation of labor.  The second theory to explain the initiation of labor is oxytocin 
initiation.  Intravenous oxytocin enhances the frequency and the intensity of uterine 
contractions that have already started and it was assumed that oxytocin also plays a role 
in initiating labor.  However, the blood concentrations of oxytocin do not increase before 
labor, which makes it unlikely to initiate labor. The third theory is decidual activation.  
Although at term, decidual activation seems to be mediated at least in part by the fetal-
decidual paracrine system (perhaps through localized decreases in progesterone 
concentration), in many cases of early preterm labor, decidual activation seems to arise in 
the context of intrauterine bleeding or an occult intrauterine infection (Romero et al., 
2006).  Pre-term labor is now believed to be a condition that is started by multiple 
mechanisms, including infection or inflammation, uteroplacental ischemia or 
hemorrhage, uterine overdistension, stress, and other immunologically mediated 
processes (Romero et al., 2006).  However, a specific mechanism cannot be defined in 
most cases; therefore, causes that are linked to pre-term birth, that are not in the casual 
pathway, have been used to describe why pre-term labor occurs. 
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Mechanisms of Pregnancy and the Onset of Labor 
Throughout pregnancy, the signaling mechanisms for myometrial contractility are 
altered first to promote relaxation and then again to promote contraction.  During labor, 
the uterus undergoes phasic contractions, which soften the cervix, dilate the cervix and 
then expel the fetus.  These processes are referred to as the latent, active and the second 
stages of labor.  Each stage is correlated with increasing intrauterine pressure, however, 
the second stage is usually accompanied by voluntary or involuntary maternal pushing 
efforts.   During the latent stage of labor, cervical dilation is less than four centimeters.  
During this stage significant and often painful contractions precede the onset of active 
labor.  The active phase of labor is referred to as uterine contractions that are sufficient 
enough to dilate the cervix from four centimeters to ten centimeters.  The cervix is dilated 
by fundal contractions that cause an outward pulling of the cervix over the intrauterine 
contents and the mechanical processes that are responsible for dilating the cervix are 
closely related to the creation of an aneurysm. In terms of creating an aneurysm, the 
fragile point of the sphere is the lower uterine segment, which is much thinner and 
generates comparatively less tension.  When the intrauterine pressure increases, it results 
in a bulging of this area, followed by additional thinning; making this process 
mechanistically similar to the creation of an aneurysm. The second stage of labor 
involves the expulsion of the fetus and occurs while the uterus is undergoing phasic 
contractions. Delivery is usually assisted by maternal pushing efforts.  Lastly, the uterus 
undergoes a tonic contraction in order to shear and expel the placenta during the third 
stage of labor. This tonic contraction is believed to reduce bleeding and failure of this 
	   4	  
tonic contraction results in post-partum hemorrhage.  These functional changes occur 
over months (increasing capacity), to days (upregulation of the contraction-associated 
proteins), to hours (onset of phasic contractions), to minutes (change to tonic contraction) 
(Young, 2007).  These natural processes are controlled by physical, biochemical, and 
hormonal signals from not only the mother, but the fetus, membranes, and placenta as 
well. The end result of this rich mixture of influences leads to a robust, yet self-protective 
physiological system.  
Key Hormones in Pregnancy 
The endocrinology of human pregnancy involves endocrine and metabolic 
changes that result from physiological alterations at the boundary between mother and 
fetus (Kumar et al., 2012). Estrogen is an essential hormone during pregnancy.  
Pregnancy does not proceed without the guidance of estrogen.  In women, estrogen is 
produced mainly in the ovaries; it is also produced by fat cells and the adrenal glands. At 
the beginning of puberty, estrogen plays a role in the development of secondary sex 
characteristics, such as breasts, pubic hair and armpit hair. Estrogen also helps regulate 
the menstrual cycle, controlling the growth of the uterine lining during the first part of the 
cycle. If the woman's egg is not fertilized, estrogen levels decrease sharply and 
menstruation begins. If the egg is fertilized, estrogen works with progesterone, another 
hormone, to stop ovulation during pregnancy (Bradford, 2016). 
Progesterone is made first by the ovaries and then by the placenta during the 
second trimester.  Progesterone has many roles such as making sure the placenta is 
functioning properly and that the uterine lining is healthy and thick. Studies have proven 
that progesterone stimulates the secretion of Th2 and reduces the secretion of Th1 
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cytokines, which is important for maintaining pregnancy (Csapo, 1973).  During early 
pregnancy, the maternal levels of 17 α-hydroxyprogesterone increases, marking the 
activity of the corpus luteum. By the tenth week of gestation, 17 α-hydroxyprogesterone 
returns to baseline levels, indicating that the placenta has a decreased amount of 17α-
hydroxylase activity. However, beginning in the thirty second week there is a second, 
more steady increase in this compound because the placenta utilizes fetal precursors. 
Progesterone also prepares and preserves the endometrium to allow implantation earlier. 
Studies have shown that the human corpus luteum makes a substantial amount of 
estradiol, however, progesterone and not estrogen is required for successful implantation 
(Rothchild, I. 1983). 
Oxytocin is made in the hypothalamus and secreted into the bloodstream by the 
posterior pituitary gland. In the body, the two main functions of oxytocin are contracting 
the uterus during childbirth and lactation. Oxytocin stimulates uterine muscles to contract 
and also increases the production of prostaglandins, which increase the contractions even 
more. Manufactured oxytocin is sometimes given to induce labor if it has not started 
naturally.  Manufactured oxytocin can also be used to strengthen contractions to help 
childbirth (Husslein, 1983). 
Anatomy: The Female Reproductive System 
The human female has a reproductive system located in the pelvis. The vagina is a 
muscular, hollow tube that extends from the vaginal opening to the uterus. Because it has 
muscular walls, it can expand and contract. The vagina has several functions such as 
being the pathway that a baby takes out of a woman's body during childbirth, and as the 
route for menstrual blood to leave the body from the uterus. The vagina connects with the 
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uterus at the cervix.  The uterus contains some of the strongest muscles in the female 
body. These muscles are able to expand and contract to accommodate a growing fetus 
and then help push the baby out during labor. When a woman isn't pregnant, the uterus is 
only about 3 inches long and 2 inches wide. At the upper corners of the uterus, the 
fallopian tubes connect the uterus to the ovaries.  The ovaries produce, store, and release 
eggs into the fallopian tubes in the process of ovulation. (Pineda et al., 2003).  
The Uterus 
Even though the uterus is composed of connective tissue, blood vessels and some 
afferent nerves, the smooth muscle cell is the dominant cell type. The majority of the 
uterine wall is made up of smooth muscle that is organized into bundles, which in turn 
are organized into fasciculata (Young, 1999).  The pregnant uterus is a unique organ and 
is only functional for a small portion of a woman’s life, if at all.  It is essential that the 
uterus function well not only for the preservation of that organism but also for the 
preservation of the species. The uterus is responsive to local environment and will change 
function in response to different endocrine signals.  The uterus is unique because it can 
accommodate many functional modifications needed for a normal pregnancy. The first 
function of the uterus occurs during the implantation stage, which is when the uterus 
accepts and implants the fertilized ovum.  The second major function of the uterus is the 
capacity to become larger in order to contain the fetus and the placenta, permitting for 
thirty-eight weeks of growth and development.  During these first two stages, there is 
very little hyperplasia, however, the degree of hypertrophy is significant from a seventy 
five gram uterus to a one thousand, three hundred gram uterus, with supplementary 
angiogenesis and vascular changes that are needed to supply nutrients to itself and 
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provide nutrients to the fetus.  During fetal development it is important that the uterus not 
contract.  The third function is that the uterus has to sense a signal from the fetus in order 
to prepare for labor.  This stage, in general, is referred to as an up regulation of the 
contraction-associated proteins (Young, 2007).  Recent studies from Mendelson’s lab 
have demonstrated the signal is a surfactant protein (SP-A) and originates from the type 
II alveolar cells (Condon et al., 2004). 
Uterine Contractions 
Uterine contractions are a major part of childbirth and its function is dependent on 
the actions of smooth muscle. There are four main types of smooth muscle tissue which 
are distinguished by the type of contraction, such as whether the contraction is tonic or 
phasic and whether or not the muscle is excited by electrical stimulation, such as 
generating an action potential (Bülbring et al., 1987).  The uterine muscle is very 
excitable and generally undergoes spontaneous rhythmic contractions that vary in 
frequency and amplitude. In order for a multicellular muscle to contract as an organ, the 
contraction of individual cells have to be coordinated by the sequential depolarization of 
cells.  The uterus contracts as a three-dimensional system of cells and the individual 
responses are communicated to neighboring cells in a specific pattern.  When one cell is 
depolarized it leads to the activation of only neighboring non-depolarized cells so that a 
wave of activation proceeds in a certain direction.  This process is required for organized 
contractions and consequently the transportation of the uterine contents.  However, 
during gestation, this coordination is much less effective than during labor, which allows 
gestation to be maintained (Reimer et al., 1998). Depolarization of the uterine muscle 
cell, when the membrane potential is made more positive relative to the resting state, 
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happens when an action potential is initiated through the regenerative influx of cations.  
In the uterine smooth muscle cells, the depolarizing action potential current is carried by 
calcium ions, which enter via voltage-gated calcium channels (Wray 1993). A variety of 
hormones, neurotransmitters, and pharmacologic agents influence the contractile state of 
uterine smooth muscle cells.  Ultimately, the ability of any of these agents to affect 
response is governed by the final common pathway of calcium ion mobilization, which 
couples excitation to contraction. (Fuchs 1995).  
Female Mouse Reproductive System: Uterine Horn 
The mouse uterus has a different anatomy than that found in humans such that it 
is made up of two horns and a single body (corpus). The uterine horns begin at the 
oviducts and come together at the body of the uterus. The body of the mouse uterus is 
composed of a cranial portion, which contains two cavities separated by a medial septum, 
and a caudal portion, which leads to the cervix.  The wall of the uterus consists of, from 
inside to outside, the endometrium, myometrium (inner circular and outer longitudinal 
smooth muscle layers), and adventitia (Uterus – Overview). The two uterine horns are 
joined caudally in a Y fashion to form the undivided uterine body and cervix. When 
autopsied, the length of a horn of the intact reproductive tract is approximately three 
times greater than the combined length of the corpus and cervix, which is about 3-5 mm.  
The cervix is projected about 1-2 mm into the cranial portion of the vagina.  The mid-
dorsal and mid-ventral outer surfaces of the cervix are fused with the adjacent inner 
surfaces of the vagina.  Each uterine horn is attached along its length to the dorsolateral 
body wall by the mesometrial ligaments, which extended caudally to the dorsal wall of 
	   9	  
the corpus (Leppi, T. J. 1964). This will serve as the birthing track for multiple mouse 
pups. 
Reproductive Characteristics of Female Mice 
Female mice reach sexual maturity at five to eight weeks and have an estrous 
cycle of approximately four days.  The gestation period is 18.5 to 21 days, and the litter 
size ranges from two to more than twelve pups. Female mice have a productive breeding 
life of seven to eight months (Silver, 1995). These mice have reproductive states 
consisting of cycling, pregnant, pseudo pregnant, anestrus (seasonal non-cycling) and 
reproductively senescent.  The first stage of the estrous cycle is called proestrus and lasts 
for thirteen hours, the second stage is the estrous –ovulation stage and lasts for fifteen 
hours. The third stage is metestrus and lasts for thirteen hours and the final stage of the 
estrous cycle is diestrus and lasts for fifty-six hours.  
Muscle: Smooth Muscle 
Smooth muscle is a major component of the uterus and is organized as an 
involuntary and non-striated muscle.  Smooth muscle is divided into two subgroups; the 
single-unit and the multiunit smooth muscle. Within the unitary cells the whole sheet 
contracts as a syncytium (a multinucleate mass of cytoplasm that is not divided into 
cells).  Smooth muscle can be found within the walls of blood vessels (vascular smooth 
muscle) such as in the aorta, small arteries, arterioles and veins.  Smooth muscle is also 
found in the urinary bladder, uterus (uterine smooth muscle), male and female 
reproductive tracts and in the gastrointestinal tract.  The structure and function is 
essentially the same in smooth muscle cells from different organs, however, the stimuli 
that induces the muscle differs significantly in order to perform individual effects in the 
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body at certain times (Mecham et al., 1995).  The dense bodies and the intermediate 
filaments that are networked throughout the sarcoplasm, cause smooth muscle fibers to 
contract.  A series of axon-like swellings, referred to as varicosities, from autonomic 
neurons form motor units through the smooth muscle (Mecham et al., 1995).  The 
molecules myosin and actin, interact together to cause contraction, and take up a 
substantial portion of the volume of the cytoplasm of smooth muscle cells.  Smooth 
muscle contains significant proteins such as: calmodulin, calponin and caldesmon.  
Calmodulin has a regulatory role in smooth muscle, calponin is a load bearing protein 
and caldesmon enhances the ability of smooth muscle to maintain tension (Aguilar et al., 
2010). 
Smooth Muscle Contraction 
In order for uterine contraction to occur, myosin and actin filaments within the 
smooth muscle must slide over one another.  In order for this to happen, energy is 
required by the hydrolysis of ATP.  Myosin works as an ATPase using ATP to generate a 
molecular conformational change of part of the myosin and produces movement. The 
movement of the filaments over each other occurs when the globular heads protruding 
from myosin filaments attach and interact with the actin filaments to from cross-bridges.  
The myosin heads tilt and drag the actin filament a short distance that is about ten to 
twelve nanometers. The myosin heads then let go of the actin filament and then changes 
to move to another site on the actin filament that is a larger distance away.  Unlike 
cardiac and skeletal muscle, smooth muscle does not contain the calcium-binding protein 
troponin. Contraction is started by a calcium-regulated phosphorylation of myosin, rather 
than a calcium-activated troponin system.  Smooth muscle may either contract phasically 
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or tonically. Phasic contractions are defined as rapid contraction and then relaxation and 
tonic contractions are defined as slow and sustained contraction.  Cross-bridge cycling 
cannot happen until the myosin heads are activated which allows for the cross-bridges to 
form. When the light chains are phosphorylated, they become active and contraction will 
occur. Myosin light-chain kinase (MLCK) phosphorylates the light chains. In order to 
control contraction, MLCK functions only when the muscle is stimulated to contract. 
Stimulation increases the intracellular concentration of calcium ions. The Calcium ions 
bind to calmodulin, and form a calcium-calmodulin complex. This complex binds to 
MLCK to activate it, allowing the chain of reactions for contraction to occur (Aguilar, 
2010).  
Hormones, Neurotransmitters and Molecules: Endocrinology Review  
The endocrine system controls the way that the body functions.  This system is a 
collection of glands that produces hormones that travel to all parts of the body in order to 
maintain the tissues and organs.  Hormones go directly into the blood stream in order to 
control metabolism, growth and sexual development.   The glands that make up the 
endocrine system are: the hypothalamus, pituitary gland, pineal gland, thyroid gland, 
parathyroid glands, adrenal glands, pancreas, thymus, testes (male) and ovaries (female) 
(Thyroid UK - An Overview of the Endocrine System). 
HPA Axis  
The HPA axis is a set of relationships and signals that occur between the 
hypothalamus, the pituitary gland and the adrenal glands.  The ‘H’ in HPA stands for 
Hypothalamus, which is a very small part of the brain that is located centrally.  The 
hypothalamus receives messages from all over the body and it also keeps the body 
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balanced by sending out messages to the nervous system via the brain.  The 
hypothalamus sends messages from the brain to the adrenals, the pituitary and other 
organs, so it is generally considered to be the starting point in the HPA axis.  The 
hypothalamus contains neurosecretory neurons, which synthesize peptides and 
catecholamines; these are released into the circulatory system and act as hormones. Some 
hypothalamic hormones are released into the systemic circulation to target distant tissues. 
Other hypothalamic hormones are released in the portal circulation for delivery to the 
anterior pituitary where they stimulate or inhibit release of the anterior pituitary 
hormones (HPA Axis Dysfunction). All the hypothalamic hormones are peptides except 
dopamine, which is a catecholamine. 
The ‘P’ in HPA axis stands for the pituitary gland. The pituitary gland is smaller 
than the hypothalamus, however, it produces a large number of hormones that the body 
needs.  The pituitary gland has two lobes, the posterior lobe and the anterior lobe.  The 
posterior pituitary contains mostly axon terminals of the hypothalamic neurosecretory 
cells. These axon terminals are surrounded by the inferior hypophyseal artery capillary 
bed. Antidiuretic and oxytocin are the two hormones released by the posterior pituitary. 
The Antidiuretic hormone is responsible for osmotic homeostasis. Oxytocin mostly acts 
at the uterine smooth muscle and the smooth muscle in the mammary glands.  There are 
six types of cells in the anterior pituitary, named after the primary peptide/protein 
hormones they produce: ACTH (adrenocorticotropin), TSH (thyroid stimulating 
hormone), FSH and LH (follicle stimulating and luteinizing hormone or gonadotropins), 
GH (growth hormone) and prolactin (lactotropin). Upon stimulation of the anterior 
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pituitary by hypothalamic hormones, these hormones are released and diffuse into the 
second portal capillary bed (Mitrovic, n.d). 
The “A” in HPA axis stands for the adrenal glands.  The adrenal gland consists of 
two endocrine glands: the adrenal medulla, which secretes catecholamines; and the 
adrenal cortex, which secretes steroid hormones. The adrenal medulla is in effect an 
enlarged and specialized sympathetic ganglion whose neuronal cell bodies do not have 
axons, but release catecholamines directly into the blood. Adrenal medullary secretion is 
under sympathetic control by way of the greater splanchnic nerve.  
The HPG Axis 
The female reproductive system is regulated by the HPG axis, which stands for the 
hypothalamic- pituitary-gonadal axis. It starts in the brain, where the hypothalamus and 
the pituitary are located and allows the brain to communicate with ovaries using 
hormones.  In terms of reproduction, the two main jobs of the hypothalamus involve the 
gonadotropin-releasing hormone (GnRH).  This hormone is responsible for initiating 
puberty and regulating the hormones that are involved in female reproduction.  GnRH is 
the first hormone in the HPG pathway and once it is produced it is released into a series 
of capillaries in the brain, hypophyseal-portal system.  These blood vessels connects the 
hypothalamis to the anterior pituitary making it possible for them to communicate with 
each other.  The binding of GnRH stimulated these cells to produce luteinizing hormone 
(LH) and the follicle-stimulating hormone (FSH), and then these hormones are secreted 
into the bloodstream.  Once into the bloodstream these hormones signal the ovaries to 
produce estrogen and inhibin both of which play essential roles in the female 
reproductive cycle.  
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In terms of the productive cycle, the preparation of the ovarian follicule is through 
a positive feedback loop that involves estrogen and luteinizing hormone.  Once the 
ovarian follicule is released into the uterus, the ovary starts to produce progesterone.  
Progesterone has a negative effect on the positive feedback loop of estrogen and 
luteinizing hormones because it inhibits the hypothalamus.  Progesterone is produced by 
the fetus if conception occurs. 
Estrogen 
In females, synthesis of estrogens begins in theca interna cells in the ovary, by the 
synthesis of androstenedione from cholesterol.  Androstenedione is a substance of weak 
androgenic activity, which serves predominantly as a precursor for more potent 
androgens such as testosterone as well as estrogen.  This compound crosses the basal 
membrane into the surrounding granulosa cells, where it is converted immediately into 
estrone and sub sequentially into estradiol (Yogeeswar, 2005).  There are two estrogen 
subtypes, ER alpha and ER beta.  The alpha receptor contains a region that promotes 
transcription activation and the beta receptor is similar to the alpha receptor however it 
contains a repressor domain.  The three major naturally occurring estrogens in women 
are estrone (E1), estradiol l (E2), and estriol (E3). 
 Estradiol is the predominant estrogen during reproductive years both in terms of 
absolute serum levels as well as in terms of estrogenic activity. During menopause, 
estrone is the predominant circulating estrogen and during pregnancy estriol is the 
predominant circulating estrogen in terms of serum levels (Files et al., 2011) Though 
estriol is the most plentiful of the three estrogens it is also the weakest, whereas estradiol 
is the strongest with a potency of approximately eighty times that of estriol (Files et al., 
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2011).  Thus, estradiol is the most important estrogen in non-pregnant females who are 
between the menarche and menopause stages of life.  The effects that estrogen has on the 
uterus includes myoplasia of myometrium and cervix, increases uterine vascularity, 
regenerates the endometrium after menstruation and is responsible for proliferative 
hyperplasia of endometrium and it has a stimulant effect on the glands of endocervix and 
their mucus secretion. 
Many of the effects of estrogens on the uterus are regulated by ER alpha, which is 
the main estrogen receptor in the mature organ.   In the undeveloped uterus, ER alpha and 
ER beta are expressed at similar levels in the epithelium and stroma, and 17 beta-
estradiol (E2) treatment reduces ER beta in the stroma.  The transcriptional effects of E2 
in the body are regulated by two different estrogen receptors, ER alpha and ER beta. A 
definitive role for ER alpha, stimulated by E2, was confirmed in adult female ER alpha 
knockout mice, where there was loss of estrogen responsiveness (Lubahn et al., 1993) as 
well as in mice with disruption of the estrogen-responsive ring finger protein gene 
(Orimo et al., 1999). Estrogen regulates target genes in a cell-specific manner which has 
various effects on different types of cells in the uterus. In the immature, twenty-one day-
old mouse uterus, the cellular proliferation rate is very low (Li, 1994). Proliferation starts 
at puberty in response to cycling estrogen, although the immature uterus is fully capable 
of responding to E2 where estrogen can induce both epithelial and stromal cell 
proliferation (Martin et al., 1973). Although ER alpha is expressed in the epithelium, 
proliferation of epithelial cells in response to E2 is thought to be indirect through growth 
factors secreted by the stroma in response to estrogen. ER alpha plays an important role 
in differentiation by regulating target genes such as that for the progesterone receptor. 
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Progesterone  
According to (Kin et al., 2010), progesterone is an endogenous steroid hormone involved 
in the menstrual cycle, pregnancy, and embryogenesis of humans.  Progesterone is 
produced in high amounts in the ovaries, by the corpus luteum, from the beginning 
of puberty to menopause.  Progesterone has a lot of physiological effects that are 
amplified when the estrogens are present (Kastner et al., 1990). Progesterone is 
sometimes referred to as the "hormone of pregnancy", and it has many roles that relate to 
the development of the fetus. Progesterone transitions the endometrium to its secretory 
stage to prepare the uterus for implantation (Patel et al., 2015).  At the same time, 
progesterone has an effect on the vaginal epithelium and cervical mucus, making it thick 
and impenetrable to sperm (Patel et al., 2015).  If pregnancy does not occur, progesterone 
levels will reduce, leading the female human to menstruation.  If ovulation does not occur 
and the corpus luteum does not develop, levels of progesterone may be low, which could 
lead dysfunctional uterine bleeding. During implantation and gestation, progesterone 
appears to decrease the maternal immune response to allow for the acceptance of the 
pregnancy.  Progesterone also reduces contractility of the uterine smooth muscle.  A 
decrease in progesterone levels is possibly a mechanism that facilitates the onset of labor. 
Progesterone acts on the uterus to cause myo-hyperplasia and by increasing the strength 
but diminishing the frequency of uterine contraction.  
Oxytocin 
 Oxytocin is a nine-amino acid peptide that is synthesized in hypothalamic neurons 
and then transported down axons of the posterior pituitary for secretion into the blood 
(Bannink, 2012).  Oxytocin is secreted within the brain from tissues such as the ovaries 
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and testis and also stimulates the contraction of the uterus during labor.  Studies have 
shown that oxytocin mediates three main effects: stimulation of milk ejection, stimulation 
of uterine smooth muscle contraction at birth and the establishment of maternal behavior.  
In terms of stimulating uterine contraction, at the end of gestation, the uterus has to 
contract forcefully and for a long period of time in order to deliver the fetus.  During the 
later stages of gestation, the amount of oxytocin receptors on uterine smooth muscle cells 
increases. Oxytocin is released during labor when the fetus stimulates the cervix and 
vagina, and it enhances contraction of uterine smooth muscle to facilitate birth. 
Dopamine 
Dopamine is a naturally occurring catecholamine, an immediate biochemical 
precursor of the norepinephrine found in adrenergic neurons and it is also a 
neurotransmitter in the central nervous system, where it is released from dopaminergic 
neurons to act on specific dopamine receptors (Craig et al., 2004).  The effect of 
dopamine on the myometrium of the uterine smooth muscle is to inhibit contractions. 
Research by Czerski et al, (2005), showed that the addition of dopamine to the incubation 
bath at a concentration of 0.26·10-4 mol/L did not cause any statistical differences in 
uterus motility. But a concentration of 1.3·10-4 mol/L caused a decrease in both the 
frequency (27%) and strength (63%), and a total lack in contractility at a concentration of 
2.6·10-4 mol/L 
Tyramine 
Tyramine is a naturally occurring trace amine that is synthesized from the amino 
acid tyrosine. In invertebrates, the biogenic amine, tyramine, carries out many of the 
functions usually associated with noradrenaline and adrenaline in vertebrates (Evans 
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1980; Roeder et al. 2003; Roeder 2005).  Tyramine was initially considered as only a 
metabolic precursor for octopamine, which cross-reacted with receptors that were 
specific for octopamine. However, evidence is now emerging for specific roles for 
tyramine in insects and nematodes, independent from those of octopamine. Thus, 
tyramine has been shown to cause opposite behavioral effects to octopamine in a number 
of insect preparations (Lange 2008). Furthermore, genetic studies have shown a role for 
tyramine in insect olfaction (Kutsukake et al. 2000) and on the inhibition of egg laying 
and the modulation of reversal behavior and the suppression of head oscillations in 
response to touch in C. elegans (Alkema et al. 2005).  In humans, tyramine acts to release 
catecholamines made by the adrenal glands into the bloodstream. Some of the substances 
that can be released include dopamine, norepinephrine and epinephrine (Starke, 1974). 
When these hormones are in the bloodstream, systolic blood pressure and heart rate can 
rise.  This rise in blood pressure can often be dangerous for people who take monoamine 
oxidase inhibitors. Since the enzyme monoamine oxidase is the mechanism the human 
body typically uses to rid itself of excessive amounts of tyramine, if MAOIs are taken, 
tyramine levels may build up, leading to increased risk of a stroke. This is why many 
people taking MAOIs are advised to avoid foods containing tyramine (Phillips & 
Arevalo, 2017). 
Neurotransmitters 
Each neurotransmitter is synthesized from a specific amino acid through a series 
of steps that require specific cofactors. Neurotransmitters are endogenous substances that 
act as chemical messengers by transmitting signals from a neuron to a target cell across a 
synapse.  Neurotransmitters are generally classified into two main categories related to 
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their overall activity; excitatory or inhibitory. Excitatory neurotransmitters exert 
excitatory effects on the neuron, thereby, increasing the likelihood that the neuron will 
fire an action potential. Inhibitory neurotransmitters exert inhibitory effects on the 
neuron, thereby, decreasing the likelihood that the neuron will fire an action potential.  
Some neurotransmitters can exert both excitatory and inhibitory effects depending upon 
the type of receptors that are present.  In addition to excitation or inhibition, 
neurotransmitters can be broadly categorized into two groups defined as small molecule 
neurotransmitters or peptide neurotransmitters. Many peptides that exhibit 
neurotransmitter activity also possess hormonal activity since some cells that produce the 
peptide secrete it into the blood where it then can act on distant cells. Catecholamine 
neurotransmitters exhibit peripheral nervous system excitatory and inhibitory effects.  
The excitatory effects are exerted upon smooth muscle cells of the vessels that supply 
blood to the skin and mucous membranes.  The main effects of the catecholamines are 
exerted as neurotransmitters upon their stimulated release from presynaptic nerve 
terminals in the appropriate target organ. However, release of the catecholamines from 
adrenal medullary cells to the systemic circulation allows them to function as hormones 
as well. Regardless of their site of release, the catecholamines exert their effects by 
binding to receptors of the G-protein coupled receptor (GPCR) family. The 
catecholamines are also known as adrenergic neurotransmitters and the neurons that 
secrete them are referred to as adrenergic neurons.  The adrenergic receptors are all 
members of the GPCR family. There are two distinct types of adrenergic receptor 
identified as the α (alpha) and β (beta) receptors. The α1 receptors induce contraction of 
smooth muscle in the uterus (Brief	  Overview	  of	  Human	  Nervous	  System). 
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Blood Brain Barrier 
The blood-brain barrier protects the neural tissue from changes in blood 
composition and toxins.  Elsewhere in the body, the extracellular concentrations of 
hormones, amino acids and potassium influence numerous changes, especially after 
meals, exercise or stressful situations.  Since many of these molecules control neuronal 
excitability, a similar change in the composition of interstitial fluid in the central nervous 
system can lead to uncontrolled brain activity.  The endothelial cells forming the blood-
brain barrier are highly specialized to allow precise control over the substances that enter 
or leave the brain (Blood Brain Barrier and Cerebral Metabolism). In terms of pregnancy, 
there is controversy regarding whether peripherally administered oxytocin crosses the 
blood-brain barrier. In theory, oxytocin is unable to cross the blood brain barrier because 
of its large size and because it is hydrophilic, however, some animal studies have 
reported low levels of oxytocin found in the brain following administration in the blood 
(Ermisch et al., 1985). Additionally, there are some electrophysiology-based animal 
studies that indicate that maternal oxytocin plays a neuroprotective role within the fetal 
brain during the birth process. This would mean that it would have to cross both the 
placental barrier and fetal blood-brain barrier (Khazipov, 2008). Findings from these 
studies suggest that maternal oxytocin inhibits certain excitatory fetal neurons from firing 
thereby protecting them during the birth process. 
Investigation of Tyramine 
Biogenic amines (BAs) are defined as low molecular weight organic bases with 
biological activity. They are formed and degraded as part normal metabolism within 
plants and animals and perform important physiological functions (Ladero, 2010, Lee et 
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al., 1991, Nielsen et al., 1971, Toda et al., 1978).  Tyramine is a biogenic amine that is 
derived from phenylalanine, which occurs in the body in trace amounts.  Phenylalanine is 
an essential amino acid that is converted to tyrosine primarily in the liver by 
phenylalanine hydroxylase. Blood borne tyrosine, derived from dietary proteins and from 
phenylalanine metabolism, enters the brain by a low affinity amino acid transport system. 
Tyrosine in brain extracellular fluid is taken up into catecholamine neurons by high and 
low affinity amino acid transporters. The relative circulating levels of tyrosine and 
phenylalanine can affect central catecholamine metabolism, as these amino acids 
compete for transport into the brain, and for transport into the neuron (Berry et al., 1996).  
After the conversion to tyrosine, it is then metabolized to catechol derivatives, which may 
play important roles as neurotransmitters. The route of formation of the catecholamines is 
from the decarboxylation of tyrosine into tyramine, and then conversion to dopamine 
(Fig. 2.).  
Tyramine can participate in cardiovascular regulations through its indirect 
sympathomimetic effects and interactions with the metabolism of catecholamines. The 
intake of food rich in tyramine by patients receiving MAO inhibitors leads to 
hypertensive crisis (Horwitz et al., 1964).  Tyramine is detected in all types of cheeses 
but is in highest concentration in samples of Camembert and Brie cheeses.  The “cheese 
effect” is the hypertensive crisis induced by dietary tyramine with monoamine oxidase 
inhibitors (MAOIs) drugs.  Tyramine is a powerful agent and has 1/20-1/50 the potency 
of adrenaline in the production of a temporary hypertension. Tyramine is the toxic agent 
in cheese for patients treated with potent monoamineoxidase inhibitors, such as 
tranylcypromine. Normally this amine is rapidly degraded to its non-toxic derivative, p-
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hydroxyphenylacetic acid, but in the presence of the enzyme inhibitor it persists in body 
fluids for a consider-able period of time. In humans, intravenous or subcutaneous 
injection of 20-80 mg of tyramine will cause a marked rise of systolic blood-pressure, 
slowing of the heart, with increased cardiac output. The effects begin within 10-12 
minutes after subcutaneous injection, and last 5-35 minutes.  After MAO inhibition, 
tyramine will displace catecholamines from synaptic vesicles, increasing their release and 
resulting in acute hypertension (Asatoor et al., 1963). 
Concluding Summary 
The role of tyramine in the mammalian reproductive cycle is unknown but 
preliminary research conducted in this study suggests that it has an important role. The 
presence of tyramine in mammalian tissues has been established beyond controversy. As 
a phenylalanine derivative, tyramine is structurally related to catecholamines and to 
therapeutically active medications.  Tyramine has some but not all of the properties 
necessary to be considered a neurotransmitter.  Its mechanism of action is mainly related 
to its ability to release catecholamines. In this study, tyramine is being investigated for its 
role in causing contractions within the mouse uterus. These studies have identified that 
the primary tyramine receptor, TAAR1 (trace amine-associated receptor 1), is present 
within the mouse uterus of pseudo-pregnant mice which increases upon contraction of the 
uterine muscle. The data presented in this thesis illustrates the role of tyramine within the 
mouse uterus and by understanding its source of modulation, inhibiting the production of 
tyramine may be a possible mechanism to help control pre-mature labor. 
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Fig. 1. Diagram of the HPG Axis. 
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Fig. 2. Biochemical synthesis of Tyramine from Tyrosine. 
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Chapter 2.  Localization of Tyramine in the Mouse Uterine Horn 
Abstract 
Pregnancy and the birthing process are natural events but still little is known 
about the signaling mechanism(s) that induce contractions. Globally, premature labor 
occurs in 12% of all pregnancies resulting in 15 million babies born preterm. Even 
though the cause of preterm labor can vary, understanding the signaling pathway that 
regulates muscle contraction could provide additional treatment options to stop premature 
labor. The uterus is composed of smooth muscle and in conjunction with the associated 
nerve fibers, forms a plexus which covers the muscle fibers. The plexus has swollen areas 
called varicosities that contain neurotransmitters. Within the uterine tissue, the smooth 
muscle receives opposing inputs from the sympathetic and parasympathetic parts of the 
ANS. Smooth muscle can be stimulated or modulated by many sources such as 
neurotransmitters (i.e. norepinephrine), hormones (i.e. epinephrine) and chemicals (i.e. 
nitrous oxide). This study researches an alternative modulator of smooth muscle activity, 
a monoamine produced in the catecholamine biosynthesis pathway called tyramine. 
During catecholamine biosynthesis, dopamine, tyramine, octopamine, and norepinephrine 
are all derived from the tyrosine precursor (Fig. 2.). Tyramine is known to be associated 
with peripheral vasoconstriction, increased cardiac output, increased respiration, elevated 
blood glucose and release of norepinephrine. This research has found tyramine and its 
specific receptor TAAR1 to be localized at uterus in relation to muscular contraction and 
has a frequency and amplitude similar to that of oxytocin.  
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Introduction 
 The female reproductive tract is made up of a series of embryonically related yet 
specialized organs that coordinate sexual activity, conception, fetal growth and 
parturition. Many of these functions depend on the coordinated contraction of smooth 
muscle.  Motility along the length of the reproductive tract is synchronized by a 
combination of phasic contractile activity and nervous control, which are heavily 
influenced by hormones and other modulators such as peptides and biogenic amines 
(Garvina et al., 2014). 
 The growth and development of the female reproductive tract are regulated in part 
by estrogen and progesterone (Pillai et al. 1999, Yan et al. 2008). The physiological 
effects of estrogen and progesterone are mediated by interaction of the hormone with 
specific intracellular estrogen receptors (ER) and progesterone (PR) receptors (Meikle et 
al. 2001).   Throughout pregnancy, Progesterone is important because it prevents 
contractions by promoting smooth muscle relaxation.  Estriol is a form of estrogen that is 
also predominant during childbirth. As estriol increases, it prevents the synthesis of 
progesterone and prepares the smooth muscles of the uterus for labor. Estriol and other 
estrogens increase the sensitivity of smooth muscles in the uterine wall to the hormones 
that will stimulate uterine contractions. Estrogen, or E2, increases the number of uterine 
oxytocin receptors in late pregnancy, preparing the uterus for contractions associated with 
labor. Oxytocin is the strongest stimulator of uterine contractions while dopamine will 
decrease uterine contractions in a dose dependent manner. These are all know modulators 
of uterine smooth muscle contraction but this project focused on a newly identified 
modulator, tyramine. 
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 The first aim of this research project was to identify if tyramine exists in the 
mammalian mouse uterine horn. It was hypothesized that if tyramine was present in the 
uterine horn, then pseudo-pregnant female mice at reproductive age would exhibit 
localization of tyramine and its specific Trace	  amine-­‐associated	  receptor	  1	  (TAAR1)	  in	  their	   uterine	   smooth	   muscle by immunohistochemistry with fluorescence and 
colorimetric 3,3′-­‐Diaminobenzidine	   (DAB) microscopy, using fixed whole or sectioned 
histological sections. Results confirmed that tyramine and TAAR1 are not only present in 
pseudo-pregnant uterine tissue but were specifically localized in non-contracted regions 
preceding contraction. 
Materials and Methods 
Animals 
Use of mice in this study was approved by Arizona State University’s Institute of 
Animal Use and Care Committee (IACUC) under the 15-1388T protocol.  Wild type 
(C57BL/6, Jackson Lab) female mice, between the ages of 6 to 8 weeks, were placed in 
cages which contained male mouse urine for 24 hours in order to stimulate pseudo-
pregnancy.  After 24 hours, the female mice were deeply anesthetized with chloroform, 
euthanized by cervical dislocation and the uterine horn was removed and placed into  
formaldehyde made 4% with phosphate buffered saline (PBS).  Each experiment was 
repeated three times with three different mice. 
Immunohistochemistry without Stimulants 
A protocol was established to isolate the uterine horn from 6-8 week old female 
wild type C57/BL/6 mice that were made pseudo-pregnant by exposure to male mouse 
urine over a 24hr period (Fig. 4.). The tissue was collected and 0.5cm sections that had 
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been processed and stabilized through fixative and permeabilization buffer were 
immunolabeled with antibodies to p-Tyramine and TAAR1.  Imaging was performed 
using whole tissue sections and a dipping objective lens so the periphery of the uterine 
horn could be observed for specific localization of signaling modulators, their receptors 
or the muscle confirmation.  
Mouse uterine horns were collected from pseudo-pregnant and non-pseudo pregnant wild 
type C57BL/6 mice (aged 6-8 weeks).  Prior to dissection, all mice were deeply 
anesthetized with chloroform and then euthanized by cervical dislocation.  Each uterine 
horn was cut into 2 pieces and placed into formaldehyde made 2% with dilution using 1x 
phosphate buffered saline (PBS) overnight in the refrigerator. The following day the 
fixative was removed and replaced with permeabilizing solution (2% formaldehyde, 1% 
Tween-20 in 1x PBS) and incubated overnight in the refrigerator. Following the fixation, 
tissues were washed for three times for five minutes in PBS containing 1% BSA. The 
tissues were then incubated overnight under gentle agitation with either mouse anti-p-
tyramine (1:1000; Millipore), rabbit anti-TAAR 1 (1:000; ThermoFisher Scientific), mouse	   anti-­‐rabbit-­‐ER	   alpha (1:000; Abcam), or anti-chicken-tyrosine hydroxylase 
antibody (1:500; Aves). Following incubation in primary antibody, the tissues were 
washed three times for five minutes each in 1x PBS containing 1% BSA. The tissues 
were next incubated overnight in either Alexa 488 (1:1000; ThermoFisher Scientific) 
anti-mouse, -rabbit or -chicken secondary antibody as well as phalloidin conjugated to 
Alexa 568 (1:500 ThermoFisher Scientific). Following incubation in secondary antibody, 
the tissues were washed three times for five minutes each in 1x PBS. Lastly, the tissues 
were incubated for 15 minutes under gentle agitation with DAPI DNA stain (1:1000, 
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ThermoFisher Scientific). The tissues were washed for five minutes in 1x PBS and then 
imaged with a 40x, 0.8NA dipping lens on the Leica SP5 confocal microscope housed in 
the WM Keck Bioimaging Laboratory at Arizona State University.  
Immunohistochemistry with Stimulants 
In order to evaluate the effect of various smooth muscle modulators, tissue 
samples were additionally collected as described above and then placed in heated and 
oxygenated ACSF (artificial cerebral spinal fluid). Each individual piece was incubated 
with either 100 nM tyramine, 10 nM dopamine, 10 nM estradiol, or 10 nM oxytocin for 
five minutes and then placed in 2% formaldehyde overnight at 40C. The formaldehyde 
was replaced with permeabilizing solution (2% formaldehyde, 1% Tween-20 in 1x PBS) 
and incubated overnight at 40C. The tissues were then washed for three times and 
followed the IHC procedure as described above.   
Paraffin Embedded Tissue Histology 
Mouse uterine horns were collected from pseudo pregnant and non-pseudo 
pregnant wild type C57BL/6 mice (aged 6-8 weeks) as described above and fixed in 2% 
formaldehyde overnight at 40C.  The fixative was removed and the tissue was rinsed three 
times in 1x PBS followed by a standard sequential dehydration in increasing 
concentrations of ethanol: 50%, 70%, 80%, 90%, 95%, 100% , followed by 100% 
toluene, 100% toluene: paraplast (1:1 ratio), and 100% paraplast.  The tissues were next 
placed in an embedding mold and allowed to solidify. Tissues were cut into10 
micrometer transverse sections using the Leica RM1950 microtome and placed on 
charged slides. The slides were then cleared using xylene and then sequentially 
rehydrated through a series of ethanol baths as shown in Fig. 3. After step 9, the tissues 
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were incubated in either the rabbit-anti-TAAR 1 (1:000; ThermoFisher Scientific) or 
mouse-anti-ER alpha antibody (1:000; Abcam) overnight in a humidified chamber. 
Following incubation, the slides were washed three times for five minutes each in 1x PBS 
containing 1% BSA.  The slides were incubated in either anti-mouse or anti-rabbit HRP 
(horseradish peroxidase 1:500, Pierce) overnight.  Following incubation, the slides were 
washed three times for five minutes each in 1x PBS.  The slides were next incubated with 
DAB (3,3′-­‐Diaminobenzidine,	   VectorLabs) for ten minutes. After washing with 
Barnstead water, the slides were counterstained with hematoxylin, sequentially 
dehydrated through a series of increasing ethanol baths, followed by xylene and mounted 
with permount.  The slides were imaged on the ThermoFisher Scientific Evos FL auto 
live cell imaging system in the WM Keck Bioimaging Laboratory at ASU. 
Frozen Tissue Sections 
Uterine horns were collected, as described above, from pseudo-pregnant and non-
pseudo pregnant wild type C57BL/6  mice (aged 6-8 weeks).  The tissues were fixed in 
4% formaldehyde overnight at 40C. The next day they were incubated in 30% sucrose 
overnight at 40C. Then the tissues were placed into individual molds containing Tissue-
Tek O.C.T. (VWR), quickly frozen in 2-proanol chilled in a liquid nitrogen container and 
then stored in a -800C freezer.  The tissues were sectioned with a Leica CM1950 cryostat 
and labeled with anti-TAAR1 and anti-ER alpha followed by anti-mouse and anti-rabbit 
Alexa 488 antibodies as described above. 
Results 
Multiple experiments were conducted to confirm the presence of tyramine and its 
specific receptor TAAR1 in the mouse uterus. These experiments were performed using 
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wild type C57BL/6 mice that were induced to exhibit pseudo-pregnancy.  Mice can 
become pseudo-pregnant after mating with a vasectomized male or being exposed to 
male urine (Fig. 4.). From an endocrinology point of view, pregnancy and pseudo-
pregnancy are identical such that there is an increase in prolactin and the corpora lutea 
becomes active and begins to secrete progesterone while the uterus starts undergoing 
changes that would normally prepare it for implantation (Dewar 1957).  
 The first aim of this project was to confirm that there was localization of p-
tyramine and its specific receptor TAAR1 in mouse uterine tissue. Confocal image results 
showed a specific localization of p-tyramine around areas of uncontracted muscle (Fig. 
5a-c.) The muscle was labeled with phalloidin that was conjugated to Alexa 568 so that 
the muscle could not only be easily identified but would show whether the tissue was 
contracted. This image brought attention to whether the role of p-tyramine was either 
preceeding or following a contraction. Similar immunolabeling was applied using the 
antibody to TAAR1 which also had increased localization at the interface of contracted 
and non-contracted muscle (Fig5 d-f.). Colocalization was also applied to the tissue to 
observe the pattern of localization between p-tyramine and TAAR1. These images 
showed clear colocalization between tyramine and its receptor TAAR1 (Fig. 5g-i.).  The 
figure inset at the top left of figure A is the secondary antibody control to ensure that 
there was not any non specifc binding of the primary antibody. 
Once it was established the both tyramine and TAAR1 were localized within the 
mouse uterine tissue it was important to observe any changes that may occur in 
localization as a result of different stimulation. Using pseudo-pregnant uterine muscle, 
tissue samples were collected and placed in an oxygenated solution of heated artificial 
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cerebral spinal fluid and then treated for five minutes with either tyramine, dopamine or 
oxytocin. It was hypothesized that the  Tissues that were not treated showed low levels of 
tyramine but when treated with either tyramine, dopamine or oxytocin, there was 
heightened localization, specically in areas that showed little contraction (Fig. 6.). Under 
closer examination of the oxytocin treated sample a unique pattern emerged where the 
muscle appeared very contracted and showing signs of muscle damage. In these regions 
there was a decreased localization of p-tyramine suggesting that oxytocin was sufficient 
to generate the contraction without the use of tyramine (Fig. 6.).    
Previous studies have shown that dopamine will modulate smooth muscle and 
cause relaxation of the muscle fibers. The image data shown in Fig. 6. showed an 
increase in p-tyramine concentration when tissue was treated with dopamine which 
would suggest that a potential role for tyramine is to generate contraction if dopamine 
induces relaxation. This would explain why there was also an increase of p-tyramine in 
dopamine treated tissues, the tissue may have a feedback mechanism utilizing tyramine to 
alternates signaling between a state of contraction and relaxation. To test this idea further, 
tissues were again situmated with the modulators; p-tyramine, dopamine or oxytocin for 
five minutes and then immunolabeled with an antibody to tyrosine hydroxylase. This 
enzyme is a necessary step in the biochemical conversion of tyrosine to dopamine (Fig. 
2.). Confocal images showed low levels of tyrosine hydroxylase in untreated tissues but 
in tissues stiulated with tyramine or oxytocin there was heightend localization and 
moderate localization in tissue treated with dopamine (Fig. 6.). In addition to labeling 
with tyrosine hydroxylase, the tissue was also labeled with the antibody to p-tyramine. 
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There was clear co-localization of p-tyramine with the tyrosine hydroxylase which 
supports the idea that tyramine and dopamine may act as antagonists of one another.  
 Imaging using whole tissue sections was very useful in observing the localization 
and state of muscle contraction of the uterus as an intact unit but there were still questions 
about where tyramine or TAAR1 were localized throughout the uterine horn. To address 
these questions, tissue was again collected and processed using either cryo-sectioned or 
paraffin embedded histological sections.  Cryo-sectioned tissue was immunolabeled with 
antibodies to estrogen receptor alpha (ERα) or TAAR1. The tissue was labeled with ERα 
because many of the effects of estrogens on the uterus are mediated by ERα, the 
predominant ER in the mature uterus, it was important to compare the localization 
patterns between ERα and TAAR1.  Confocal images showed general localization of both 
throughout the uterine tissue in both pseudo- and non-pseudo pregnant mice (Fig. 7.). 
Previous research showing estrogen receptor localization in reproductive tissue has been 
more commonly conducted using paraffin embedded tissue to obtain more precise 
localization and resolution that is lost due to light scatter in fluorescence images. Uterine 
tissue was processed initially to observe the morphology of the uterine horn cross section 
using hematoxylin and eosin staining (Fig. 8a-e.). This was also combined with 
immunostaining using anti-p-tyramine and 3,3′ -Diaminobenzidine to produce the 
brown colorimetric counterstain (Fig. 8.).  Because tyramine is an amine, it does not 
produce clean localization within the cells so tissue was again processed as paraffin 
embedded sections and then immunolabeled with either antibody to ERα or TARR1 (Fig. 
10.). Tissues labeled with ERα showed specific localization within cells along the cells of 
the lumen and within many cells throughout the peritoneum. In tissues that were labeled 
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with antibody to TAAR1, there was increased localization within cells along the lumen 
and within the peritoneum as compared to the tissues labeled with ERα. This data 
suggests that in pseudo-pregnant mouse uterine tissue that there may higher levels of 
tyramine earlier in pregnancy as compared to estradiol (E2) where it is known that levels 
of E2 will increase as pregnancy progresses. 
Discussion and Conclusions 
The first aim of this research project was to identify whether or not tyramine 
exists in the mammalian mouse uterine horn. It was hypothesized that, if tyramine was 
present in the uterine horn, then pseudo-pregnant female mice at reproductive age would 
exhibit localization of tyramine and its specific trace	   amine-­‐associated	   receptor	   1	  (TAAR1)	   in	   their	   uterine	   smooth	   muscle.	   This	   was	   visualized by 
immunohistochemistry with fluorescence and colorimetric 3,3′-­‐Diaminobenzidine	  (DAB) 
microscopy, using fixed whole or sectioned histological sections to confirm its presence 
within the uterine horn. The data collected from this study confirmed that tyramine and 
TAAR1 are not only present in pseudo-pregnant uterine tissue, but they appear to be 
specifically localized in non-contracted regions preceding contraction. 
  TAAR1 is a G-protein coupled receptor preferentially activated by the trace 
amine tyramine. It has shown to be distributed throughout the brain, mainly associated 
with areas containing monoaminergic cell bodies and projections, including the limbic 
areas and the prefrontal cortex.  Within the brain, the signal transduction path through 
TAAR 1 occurs through coupling of the G protein receptor with subsequent activation of 
adenylate cyclase, generation of cAMP, and activation of protein kinase A and protein 
kinase C.  These enzymes interact with transporters such as the dopamine transporter 
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(DAT) increasing uptake (Berry, 2016). TAAR 1 has also been found to be intracellular, 
possibly associated with unknown intracellular membranes. These mechanisms explain 
the opposing affects seen between tyramine and dopamine stimulation (Fig. 5,6.) and 
why TAAR1 was found localized within cells in the histological sections (Fig. 10.).   
The data presented demonstrates that various modulators affect the way that 
tyramine is localized.  In Figure 6, tyramine was differentially localized after the tissue 
was treated with physiological amounts of either tyramine (100nM), dopamine (10nM) 
and oxytocin (10nM).  Previous studies have shown that tyramine has physiological 
effects on peripheral vasoconstriction, increased cardiac output, increased respiration, 
elevated blood glucose, and the release of norepinephrine (Ladero, 2010).  Dopamine has 
a relaxant effect on tissue and oxytocin promotes contractions that are strong enough to 
expel the fetus during birth. When the uterine horn was treated with tyramine, the tissue 
became more tight and organized; indicating that contractions were occurring and 
labeling the tissue with the p-tyramine antibody showed that the intensity of the tyramine 
signal increases significantly, especially in areas that directly precede contraction.  The 
actin filaments within the muscle fibers were visualized using the toxin phalloidin, which 
was conjugated to Alexa 568.  Using phalloidin it was possible to observe the difference 
in muscle fiber structure such that if they were more separated and are not as tightly 
organized, the tissue was in a more relaxed state or non-contracted. After the dopamine 
treatment, the muscle appears more relaxed and the amount of p-tyramine localization 
increased suggesting that its increase was to offset the muscle relaxation generated by the 
dopamine. When labeled with the p-tyramine antibody, the tyramine signal is almost non-
existent in the overly contracted areas and the signal starts to become stronger in the area 
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that is not as contracted (Fig. 6.)  which further suggests it may have a role in muscle 
contraction. This is further supported when observing the co-localization of p-tyramine 
and tyrosine hydroxylase (TH).  Tyrosine hydroxylase is the enzyme that converts 
tyrosine to L-DOPA (the precursor for dopamine).  It was observed that tyrosine 
hydroxylase would increase in concentration in response to increased tyramine 
localization (Fig. 7.) seemingly to counter its effect.  Another key observation is that in 
dopamine treated tissue, the p-tyramine and the tyrosine hydroxylase are localized to the 
same area.  Alternatively, in tissue that was treated with oxytocin, the localization of the 
p-tyramine decreases yet the localization of tyrosine hydroxylase significantly increases 
trying to counteract the extreme contractile effect that the oxytocin had on the tissue. 
During normal pregnancy, the levels of oxytocin typically stay low and do not 
dramatically increase until the time of delivery when the cervix has reached 8-10 cm 
dilation in humans (Fig. 11.).  
The data from this research indicates that tyramine and its receptor TAAR1 are 
localized within the mouse uterine tissue and suggests that it may have a role in muscle 
contraction. The next aim of this project is to identify the function tyramine has in the 
mouse uterus, which will require a physiological approach. Chapter 3 discusses the 
methods developed to study mouse uterine tissue, the observations made from these 
experiments and the future directions of this study.  
 
 
 
 
	   37	  
 
Fig. 3. Hematoxylin and Eosin staining protocol. The steps used to clear and rehydrate 
paraffin embedded tissue sections. Also included are the steps to add 
immunohistochemistry and to dehydrate and mount the slides in permount resin.   
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Fig. 4. Non-pseudo pregnant vs. pseudo pregnant uterine mouse horn.  The mouse on 
the left is not pseudo-pregnant and the uterine horn shows no swelling or enriched blood 
flow unlike the mouse on the right.  
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Fig. 5. Localization of p-Tyramine and TAAR1 in intact mouse uterine horn. 
Confocal Images of Mouse Uterus Images show the localization of anti-pTyramine [A], 
phalloidin [B], and both p-Tyr and phalloidin [C] in untreated mouse uterine tissue. 
Figures D – F show the localization of anti-TAAR1 [D], phalloidin [E] and both TAAR1 
and phalloidin [F]. In figures G-I actin is labeled with phalloidin [red] and co-localized 
with either p-Tyr [G] or TAAR1 [H]. Figure I shows localization of p-Tyr, TAAR1 and 
phalloidin. Blue is DAPI staining of DNA. Inset on fig. A. is a second antibody control. 
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Fig. 6. Tyramine localization on un-stimulated and stimulated mouse uterine tissue. 
Confocal images depict the localization of DNA [blue], p-Tyramine [green], actin [red] 
and combined overlay of either untreated or uterine tissue stimulated with tyramine, 
dopamine or oxytocin. Scale bar is 10µm.  
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Fig. 7. Co-localization of Tyrosine Hydroxylase and p-Tyramine in mouse uterine 
tissue. Confocal images depict the localization of p-Tyramine [blue], Tyrosine 
Hydroxylase [green], actin [red] and combined overlay of either untreated or uterine 
tissue stimulated with tyramine, dopamine or oxytocin. Image bar is 10 µm. 
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Fig. 8. Frozen sections and the co-localization of TAAR1 and ERα  on pseudo and 
non-pseudo pregnant mouse uterine muscle. Confocal images depict the localization of  
Actin [red], ERα [green], and TAAR 1 [grey]. Scale bar is 20 µm.  
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Fig. 9. Stained histological sections of mouse uttering horn. Figures A – D are 10µm 
transverse sections through a 6-week-old female mouse uterine horn that was stained for 
hematoxylin and eosin. The hematoxylin stains the nuclei [blue] while the eosin stains 
cytoplasmic regions, which include the muscle fibers [pink]. Fig. E. shows a complete 
cross section. Fig. F. was stained for H&E and immune-labeled with antibody against p-
tyramine and treated with 3,3′-­‐Diaminobenzidine	  to	  produce	  the	  brown	  pigment. 
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Fig. 10. ERα and TAAR1 localization in	  the	  mouse	  uterus.	  Cross	  section	  of	  mouse	  smooth	  muscle	  uterine	  tissue	  counterstained	  with	  hematoxylin	  and	  dark	  grey	  regions	  (arrows)	  in	  Fig.	  A	  are	  ERα	  and	  in	  Fig.	  B	  is	  TAAR1	  localization	  stained	  with	  3,3′-­‐Diaminobenzidine.	  Scale	  bar	  is	  100µm. 
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Fig. 11. Oxytocin levels during delivery. (Figure source Cassels, 2012) 
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Chapter 3. The Role of Tyramine in the Mouse Uterine Horn 
Abstract 
Smooth muscle tissue makes up the walls of the reproductive tract in the uterus.  
Usually, smooth muscle surrounds an organ with a hollow space or lumen, so that the 
muscles can exert pressure on the lumen. One of the hallmarks of smooth muscle tissue is 
the fact that its activity is not regulated by somatic (voluntary) motor neurons. Instead, 
smooth muscle tissue has an endogenous rhythm, and the force of contractions can be 
increased or decreased by hormones and other factors like neurotransmitters, peptides and 
amines.  This portion of the study focuses on the physiological effects induced by 
tyramine in mouse uterine muscle. 
Introduction 
The second aim of this project was to find the function of tyramine within mouse uterine 
muscle. Previous studies have shown that tyramine is associated with peripheral 
vasoconstriction, increased cardiac output, increased respiration, elevated blood glucose 
and the release of norepinephrine.  Because tyramine has been shown to be a modulator 
of smooth muscle, it was probable that tyramine could also function as an alternative 
modulator of smooth muscle within the uterus. It was hypothesized that if tyramine was a 
modulator of smooth muscle activity in the uterine horn, then uterine muscle form 
pseudo-pregnant female mice at reproductive age would exhibit contraction as measured 
by force transduction upon stimulation using tyramine.  
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Materials and methods 
Animals 
The use of mice in this study was approved by Arizona State University’s 
Institute of Animal Use and Care Committee (IACUC) under the 15-1388T protocol.  
Wild type (C57BL/6, Jackson Lab) female mice, between the ages of 6 to 8 weeks, were 
placed in cages which contained male mouse urine for 24 hours in order to stimulate 
pseudo-pregnancy.  After 24 hours, the female mice were deeply anesthetized with 
chloroform, euthanized by cervical dislocation and the uterine horn was removed and 
placed heated, oxygenated artificial cerebral spinal fluid (ACSF).  Each experiment was 
repeated three times using three different mice 
Force Transduction 
The BIOPAC Smooth Muscle Contraction apparatus (BIOPAC, Systems Inc.) 
was used to measure the contractile force of the mouse uterine smooth muscle (Fig. 12.). 
After the force transducer was calibrated, the uterine horns were collected from pseudo 
pregnant and non-pseudo pregnant wild type C57BL/6 mice (aged 6-8 weeks).   After 
dissection, the uterine horns were cut into 0.5cm length sections and placed in an 
oxygenated buffer reservoir containing heated ACSF to prevent the tissue from becoming 
hypoxic. The tissue was transferred from the reservoir to the test chamber, where it was 
attached to two heart clamps connecting one end to a holder within the chamber and the 
other end to the transducer. The test chamber also contained ACSF buffer that was heated 
and oxygenated. The tissue remained untreated for 15 minutes so the value for the 
baseline contractions could be recorded.  The tissue was then treated so the buffer within 
the test chamber had a 100 nM concentration of tyramine.  After 15 minutes, the tissue 
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and saline that was in the test chamber was discarded, and a new piece of tissue and new 
saline solution was added to a clean test chamber. This procedure was repeated with 
treatments of oxytocin (10 nM), estrogen (10 nM), octopamine (10 nM) and dopamine 
(10 nM).  Force transduction experiments were repeated at least three times individually 
as well as sequential treatments such as tyramine followed by dopamine.  
Results 
 The uterine muscle exhibits peristaltic contractions that have a defined duration, 
amplitude and frequency. In the mouse, untreated uterine muscle from pseudo pregnant 
mice had a contraction duration averaging 36 seconds, a frequency of 60 seconds and 
intensity at 0.1 grams.  The concentration of tyramine used to stimulate the uterine 
muscle was 100 nM, which is the physiological concentration known to stimulate smooth 
muscle (Fig. 13.). Upon stimulation, the average duration was reduced to 15 seconds, 
with a frequency of 60 seconds and intensity at 0.51 grams.  Because octopamine is 
within the biochemical conversion pathway following tyramine, it was also tested. 
Smooth muscle that was stimulated by 10 nM of octopamine did not induce any 
contractile activity. As a positive control, oxytocin was used to induce contractions 
within the tissue at a 10 nM physiological concentration. This resulted in an average 
duration of 15 seconds, a frequency of 60 seconds and intensity at 1.9 grams.  As a 
negative control, dopamine was used to inhibit contractions using a 10 nM physiological 
concentration. As expected, dopamine did not induce any contractile activity.  In addition 
to the physiological stimulation of the uterine tissue using a physiological concentration 
of tyramine, tissue was also tested to observe the effect that increasing concentrations of 
tyramine would have on muscle contraction. It was found that contractile strength would 
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increase as the concentration of tyramine increased (data not shown). The results of these 
measurements demonstrated that tyramine can induce contractions at a level that is 
comparable to oxytocin.   
 These experiments were repeated using non-pseudo pregnant mouse uterus. For 
untreated uterine smooth muscle, there was an average duration of 22 seconds, a 
frequency of 60 seconds and intensity at 0.19 grams.  Again, a concentration of 100 mM 
tyramine was used to treat the uterine tissue that resulted in an average duration of 32 
seconds, a frequency of 60 seconds and an intensity of 0.56 grams.  The concentration of 
E2 used to stimulate the uterine muscle was 10 nM, resulting in an average duration of 38 
seconds, a frequency of 60 seconds and an average intensity of 0.60 grams. The positive 
control stimulus of oxytocin was conducted at a 10nM physiological concentration, 
resulting in an average duration of 36 seconds, a frequency of 60 seconds and an intensity 
of 2.1 grams (Fig. 16.).  These values were graphed and compared (Fig. 16.). From the 
graph it is evident that tyramine affects the uterine horn at a similar intensity as that 
induced by E2 in the pseudo pregnant uterine muscle and that there is an approximate 
two fold increase in the effect of oxytocin as compared to stimulus in non-pseudo 
pregnant uterine muscle.  
Discussion 
The second aim of this project was to find out what tyramine’s function is within 
the mouse uterine horn. Results from this study did support the hypothesis that tyramine 
has the ability to modulate smooth muscle function and can induce contractions. These 
results also confirmed the data from Chapter 2 that showed p-tyramine and TAAR1 
localization precede contraction.  The force transduction data for the non-pseudo and the 
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pseudo pregnant uterine muscle differed in the intensity and the duration of the 
contractions. Tissues that were not treated with any modulator had low intensity 
contractions, which were expected.  Overall, the non-pseudo pregnant tissues that were 
treated with modulators had intensities that were less than the pseudo pregnant tissues 
that were not treated. The oxytocin and the dopamine treatments were used as the 
positive and negative control since both of those hormones are widely known to either 
contract or relax uterine tissue, which was reinforced in these results.  The epinephrine 
treatments did not have any significant contractile activity (data not shown).  According 
to (Segal et al., 1998), physiological concentrations of epinephrine decrease uterine 
activity by means of ß2-receptor activation. The octopamine also did not induce any 
contractile activity, which was also expected since tyramine functions independently of 
octopamine. Estradiol treatments did increase the intensity of the contractions in the 
mouse smooth muscle tissue.  The contractile strength generated by tyramine was found 
to be similar to the contractile strength induced by estrogen, which suggests a possible 
role of tyramine to also prepare the smooth muscle tone in preparation for delivery. This 
correlates with previous reports that estradiol increases uterine contractions and increases 
uterine blood flow to sustain contractions in the human uterus (Sastry et al., 1997).  
Tissues that were treated with 100nM physiological concentration of tyramine (Sotnikova 
et al., 2010) induced contractile responses that were more intense than the baseline 
response but not as intense as that induced by oxytocin. An interesting observation is that 
the frequency of contraction remained constant between untreated and treated in both 
pseudo and non-pseudo pregnant mice. Besides the direct effect of modulation on 
contractile intensity it was found that smooth muscle from pseudo pregnant mice have 
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half the duration of contraction as compared to the non-pseudo pregnant mouse tissue. 
Additionally, smooth muscle contractile duration in non-treated (no modulator added) 
mouse tissue had an opposite effect where the duration in non-pseudo pregnant mice is 
half of the value found for pseudo pregnant mice. This suggests that another potential 
modulator may be involved through the process of generating pseudo pregnancy yet it 
does not appear to change stimulant effect of tyramine but it does affect the intensity of 
oxytocin.  
Future Directions 
The results obtained in this study formed only the beginning of understanding the 
role of tyramine in the mouse uterus. They have also opened the way for many more 
questions that can be investigated such as identifying other elements and mechanisms that 
may be involved in tyramine signaling. Identifying these proteins or molecules will 
require the use of immuno-purification and mass spectrometry to identify 
upstream/downstream targets. This technique would also help validate the antibodies, p-
tyramine and TAAR1 that are used in the study. It would also be necessary to also 
quantify the levels of tyramine in the uterine smooth muscle tissue at each stage of the 
mouse estrous cycle and at various time points through the lifespan of the mouse. Future 
projects would also include measuring tyramine levels throughout pregnancy and 
specifically while the mouse is giving birth.  Recently the Baluch lab acquired LifeAct 
transgenic mice. These mice contain a transgene encoding a 17-amino acid peptide called 
LifeAct, which binds F-actin. This peptide is co-expressed with GFP which enables the 
actin cytoskeleton to be imaged both in vivo and in vitro. Actin is a key component of 
muscle tissue and this transgenic model allows researchers the ability to visualize muscle 
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contractions.  Various receptors or cell surface protein antibodies can be directly 
conjugated to fluorophores and imaged live to observe recruitment during contractile 
activity.  
These studies have identified that tyramine is a modulator of smooth muscle 
uterine activity and the primary tyramine receptor, TAAR1 (trace amine-associated 
receptor 1), is present within the mouse uterus and increases in localization preceding 
contraction of the uterine muscle. As experiments continue in the study of tyramine 
modulation, researchers will have a better understanding of pregnancy and how it is 
regulated. Through this understanding, it may be possible to create future treatments such 
as the inhibition of tyramine production, to help control pre-mature labor. 
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Fig. 12. BIOPAC system to measure contractile force. 
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Fig. 13. Force transduction measurement graphs from stimulated non-pseudo 
pregnant mouse uterine muscle. The X-axis is Time (s) and the Y-axis is the 
intensity (g) 
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Fig. 14. Force measurements compared between stimulant types from non-pseudo 
pregnant uterine muscle. [Significance measured using a one way ANOVA, p<0.05] 
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Fig. 15. Force transduction measurement graphs from stimulated pseudo pregnant 
mouse uterine muscle. The X-axis is Time (s) and the Y-axis is the intensity (g) 
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Fig. 16. Force measurements compared between stimulant types from pseudo 
pregnant uterine muscle. [Significance measured using a one way ANOVA, p<0.05]  
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Use of mice in this study was approved by Arizona State University’s Institute of Animal 
Use and Care Committee (IACUC) under the 15-1388T protocol.  Wild type C57BL/6 
mice were obtained by the Jackson Laboratory in Sacramento, California. Mice were 
housed and bred in the ASU Department of Animal Care and Technologies (DACT) 
vivarium in Life Sciences B wing.  Female mice, between the ages of 6 to 8 weeks, were 
used for this study and were placed in cages that contained male mouse urine for 24 hours 
in order to stimulate pseudo-pregnancy. 
